Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Alpenglow Biosciences
Alpenglow Biosciences digitizes intact tissue samples into quantitative 3D datasets to improve spatial biology research and clinical diagnostics. The company’s Aurora 3D Spatial Biology Platform…
Alpenglow Biosciences
Alpenglow Biosciences digitizes intact tissue samples into quantitative 3D datasets to improve spatial biology research and clinical diagnostics. The company’s Aurora 3D Spatial Biology Platform…
TL;DR
What they do: AI-enabled 3D tissue imaging and cloud analytics (Aurora 3D platform) for spatial biology and translational research
Founded: 2018 (spun out from University of Washington research)
Customers: Pharma and biotech researchers (preclinical discovery, immuno-oncology, dermatology) and clinical research partners
Funding signals: Series A (~$4M, 2021) plus multiple grants (NIH, ARPA-H, Andy Hill CARE Fund); reported total funding ~$7.85M
Company Overview
Problem Domain
Spatial biology, digital pathology, and 3D tissue imaging for translational research and drug development.
Founded
2018
Industry
Medical Equipment Manufacturing
Tech Stack
Funding Track Record
$4.0M
Reported Series A financing (~$4M)
$1.6M
Reported grant funding
Multiple NIH grants and ARPA-H contracts reported (aggregate value referenced >$24M in one summary)
$1.8M
Reported debt financing
$2.0M
Reported grant financing
Investor Signal
“Includes strategic and public research funders (Dynamk Capital, Andy Hill CARE Fund, NIH); mix of venture and grant funding”
